A Phase 2B Double-Blind Placebo Controlled Study of Two Doses of EPA-E in Patients With Nonalcoholic Steatohepatitis
Publication
, Journal Article
Sanyal, AJ; Abdelmalek, MF; Suzuki, A; Cummings, O; Chojkier, M
Published in: HEPATOLOGY
December 1, 2013
Duke Scholars
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
December 1, 2013
Volume
58
Issue
6
Start / End Page
1385A / 1385A
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Sanyal, A. J., Abdelmalek, M. F., Suzuki, A., Cummings, O., & Chojkier, M. (2013). A Phase 2B Double-Blind Placebo Controlled Study of Two Doses of EPA-E in Patients With Nonalcoholic Steatohepatitis. HEPATOLOGY, 58(6), 1385A-1385A.
Sanyal, Arun J., Manal F. Abdelmalek, Ayako Suzuki, Oscar Cummings, and Mario Chojkier. “A Phase 2B Double-Blind Placebo Controlled Study of Two Doses of EPA-E in Patients With Nonalcoholic Steatohepatitis.” HEPATOLOGY 58, no. 6 (December 1, 2013): 1385A-1385A.
Sanyal AJ, Abdelmalek MF, Suzuki A, Cummings O, Chojkier M. A Phase 2B Double-Blind Placebo Controlled Study of Two Doses of EPA-E in Patients With Nonalcoholic Steatohepatitis. HEPATOLOGY. 2013 Dec 1;58(6):1385A-1385A.
Sanyal, Arun J., et al. “A Phase 2B Double-Blind Placebo Controlled Study of Two Doses of EPA-E in Patients With Nonalcoholic Steatohepatitis.” HEPATOLOGY, vol. 58, no. 6, WILEY-BLACKWELL, Dec. 2013, pp. 1385A-1385A.
Sanyal AJ, Abdelmalek MF, Suzuki A, Cummings O, Chojkier M. A Phase 2B Double-Blind Placebo Controlled Study of Two Doses of EPA-E in Patients With Nonalcoholic Steatohepatitis. HEPATOLOGY. WILEY-BLACKWELL; 2013 Dec 1;58(6):1385A-1385A.
Published In
HEPATOLOGY
EISSN
1527-3350
ISSN
0270-9139
Publication Date
December 1, 2013
Volume
58
Issue
6
Start / End Page
1385A / 1385A
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics